Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? 2014

Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
Mood and Anxiety Program, University of Maryland School of Medicine, Baltimore, Maryland, United States of America ; Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.

BACKGROUND Phenylalanine and tyrosine are precursor amino acids required for the synthesis of dopamine, the main neurotransmitter implicated in the neurobiology of schizophrenia. Inflammation, increasingly implicated in schizophrenia, can impair the function of the enzyme Phenylalanine hydroxylase (PAH; which catalyzes the conversion of phenylalanine to tyrosine) and thus lead to elevated phenylalanine levels and reduced tyrosine levels. This study aimed to compare phenylalanine, tyrosine, and their ratio (a proxy for PAH function) in a relatively large sample of schizophrenia patients and healthy controls. METHODS We measured non-fasting plasma phenylalanine and tyrosine in 950 schizophrenia patients and 1000 healthy controls. We carried out multivariate analyses to compare log transformed phenylalanine, tyrosine, and phenylalanine:tyrosine ratio between patients and controls. RESULTS Compared to controls, schizophrenia patients had higher phenylalanine (p<0.0001) and phenylalanine: tyrosine ratio (p<0.0001) but tyrosine did not differ between the two groups (pā€Š=ā€Š0.596). CONCLUSIONS Elevated phenylalanine and phenylalanine:tyrosine ratio in the blood of schizophrenia patients have to be replicated in longitudinal studies. The results may relate to an abnormal PAH function in schizophrenia that could become a target for novel preventative and interventional approaches.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D003710 Demography Statistical interpretation and description of a population with reference to distribution, composition, or structure. Demographer,Demographic,Demographic and Health Survey,Population Distribution,Accounting, Demographic,Analyses, Demographic,Analyses, Multiregional,Analysis, Period,Brass Technic,Brass Technique,Demographers,Demographic Accounting,Demographic Analysis,Demographic Factor,Demographic Factors,Demographic Impact,Demographic Impacts,Demographic Survey,Demographic Surveys,Demographic and Health Surveys,Demographics,Demography, Historical,Demography, Prehistoric,Factor, Demographic,Factors, Demographic,Family Reconstitution,Historical Demography,Impact, Demographic,Impacts, Demographic,Multiregional Analysis,Period Analysis,Population Spatial Distribution,Prehistoric Demography,Reverse Survival Method,Stable Population Method,Survey, Demographic,Surveys, Demographic,Analyses, Period,Analysis, Demographic,Analysis, Multiregional,Demographic Analyses,Demographies, Historical,Demographies, Prehistoric,Distribution, Population,Distribution, Population Spatial,Distributions, Population,Distributions, Population Spatial,Family Reconstitutions,Historical Demographies,Method, Reverse Survival,Method, Stable Population,Methods, Reverse Survival,Methods, Stable Population,Multiregional Analyses,Period Analyses,Population Distributions,Population Methods, Stable,Population Spatial Distributions,Prehistoric Demographies,Reconstitution, Family,Reconstitutions, Family,Reverse Survival Methods,Spatial Distribution, Population,Spatial Distributions, Population,Stable Population Methods,Technic, Brass,Technique, Brass
D005260 Female Females
D006136 GTP Cyclohydrolase (GTP cyclohydrolase I) or GTP 7,8-8,9-dihydrolase (pyrophosphate-forming) (GTP cyclohydrolase II). An enzyme group that hydrolyzes the imidazole ring of GTP, releasing carbon-8 as formate. Two C-N bonds are hydrolyzed and the pentase unit is isomerized. This is the first step in the synthesis of folic acid from GTP. EC 3.5.4.16 (GTP cyclohydrolase I) and EC 3.5.4.25 (GTP cyclohydrolase II). GTP 8-Formylhydrolase,GTP Dihydrolase,GTP Ring-Opening Enzyme,7,8-Dihydroneopterintriphosphate Synthetase,GTP Cyclohydrolase I,GTP Cyclohydrolase II,7,8 Dihydroneopterintriphosphate Synthetase,8-Formylhydrolase, GTP,Cyclohydrolase I, GTP,Cyclohydrolase II, GTP,Cyclohydrolase, GTP,Dihydrolase, GTP,GTP 8 Formylhydrolase,GTP Ring Opening Enzyme,Ring-Opening Enzyme, GTP,Synthetase, 7,8-Dihydroneopterintriphosphate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
September 2006, Clinical biochemistry,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
October 1986, Molecular and cellular endocrinology,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
January 1984, The Biochemical journal,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
September 2012, Movement disorders : official journal of the Movement Disorder Society,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
April 2011, The Journal of biological chemistry,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
August 2012, Archives of neurology,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
October 2018, Reports of biochemistry & molecular biology,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
January 1999, The Turkish journal of pediatrics,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
November 2006, Archives of neurology,
Olaoluwa Okusaga, and Olesja Muravitskaja, and Dietmar Fuchs, and Ayesha Ashraf, and Sarah Hinman, and Ina Giegling, and Annette M Hartmann, and Bettina Konte, and Marion Friedl, and Jason Schiffman, and Elliot Hong, and Gloria Reeves, and Maureen Groer, and Robert Dantzer, and Dan Rujescu, and Teodor T Postolache
January 1989, Analytical biochemistry,
Copied contents to your clipboard!